vimarsana.com
  1. Home
  2. Live Updates
  3. Steroidal Nasal Spray Technology - Breaking News

Steroidal Nasal Spray Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EmphyCorp Inc Non-Steroidal N115 Nasal Spray Completed Phase III Clinical Trial for COVID-19, Long COVID-19 (Long Haulers), and Pulmonary Fibrosis

/PRNewswire/ EmphyCorp Inc. www.EmphyCorp.com, a private corporation, specializes in Rx Non-Steroidal Nasal Spray Technology. Their flagship product, N115,.

United statesRobert millarAlain martinPrnewswire emphycorp incEmphycorp incSteroidal nasal spray technologyEmphycorp cellular sciencesPulmonary fibrosisAllergic rhinitisChronic rhinitisCellular sciencesClinical trialsHauler symptomsEuropean journalSteroidal nasal sprayLong hauler

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.